Tech Company Financing Transactions

Clementia Pharmaceuticals Funding Round

On 1/10/2014, Clementia Pharmaceuticals landed $22.5 million in Series A funding from OrbiMed and BDC Venture Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series A

OrbiMed (Lead Investor) (David Bonita)

BDC Venture Capital (Jean-Francois Pariseau)

Proceeds Purpose
Proceeds from this Series A round will be used for general operational purposes and to test Clementia's lead product candidate, palovarotene in clinical studies for the treatment of FOP.

Company Information

Company Status
Acquired or Merged
Mailing Address
4150 Ste-Catherine St. West 550
Montreal QC, H3Z 2Y5
Email Address
Not Recorded
Clementia Pharmaceuticals is focused on developing palovarotene for fibrodysplasia ossificans progressiva (FOP) and other diseases.
Clementia Pharmaceuticals LinkedIn Company Profile
Social Media
Clementia Pharmaceuticals Company Twitter Account
Company News
Clementia Pharmaceuticals News
Clementia Pharmaceuticals on Facebook
Clementia Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Clarissa Desjardins
  Clarissa Desjardins LinkedIn Profile  Clarissa Desjardins Twitter Account  Clarissa Desjardins News  Clarissa Desjardins on Facebook
Chief Financial Officer
Michael Singer
  Michael Singer LinkedIn Profile  Michael Singer Twitter Account  Michael Singer News  Michael Singer on Facebook
Chief Medical Officer
Donna Grogan
  Donna Grogan LinkedIn Profile  Donna Grogan Twitter Account  Donna Grogan News  Donna Grogan on Facebook
VP - Bus. Development
Jeffrey Packman
  Jeffrey Packman LinkedIn Profile  Jeffrey Packman Twitter Account  Jeffrey Packman News  Jeffrey Packman on Facebook
VP - Sales
Eric Grinstead
  Eric Grinstead LinkedIn Profile  Eric Grinstead Twitter Account  Eric Grinstead News  Eric Grinstead on Facebook



Browse more venture capital transactions:

Prev: 1/9/2014: TraceLink venture capital transaction
Next: 1/10/2014: Vestaron venture capital transaction


Share this article


About Our VC Transactions Data

Our team works diligently to report on tech company VC transactions. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary